27761213|t|Alanine to Serine Variant at Position 986 of Calcium Sensing Receptor and Colorectal Cancer Risk
27761213|a|With regard to the effect of calcium against colorectal cancer (CRC) and considering the key role of calcium sensing receptor (CaSR) in calcium homeostasis, this study investigated whether CaSR gene rs1801725 or A986S variant was associated with susceptibility to CRC risk. This study was conducted as a case-control study and 303 cases with CRC and 354 controls were enrolled. All 657 subjects were genotyped for CaSR gene A986S variant using PCR - RFLP method. No significant difference was observed for the A986S variant of CaSR gene in either genotype or allele frequencies between the cases and the controls and this lack of difference remained non-significant even after adjustment for age, BMI, sex, smoking status, and family history of CRC. No evidence for the effect modification of the association A986S variant and CRC by BMI, sex, or tumor site was also observed. Furthermore, the risk of obesity in relation to the A986S variant in the controls and the cases was separately analyzed and we observed no significant difference between normal weight (BMI < 25kg/m(2)) and overweight / obese (BMI â‰¥ 25kg/m(2)) subjects. Our findings do not support a role for effect of the CaSR gene A986S variant on CRC risk; nevertheless, this finding requires confirmation and the role of the gene variant in carcinogenesis needs to be further investigated.
27761213	0	7	Alanine	T116,T123	C0001898
27761213	11	17	Serine	T116,T121,T123	C0036720
27761213	18	25	Variant	T080	C0205419
27761213	45	69	Calcium Sensing Receptor	T116,T192	C0249742
27761213	74	91	Colorectal Cancer	T191	C1527249
27761213	92	96	Risk	T078	C0035647
27761213	116	122	effect	T080	C1280500
27761213	126	133	calcium	T121,T123,T196	C0006675
27761213	142	159	colorectal cancer	T191	C1527249
27761213	161	164	CRC	T191	C1527249
27761213	190	194	role	T077	C1705810
27761213	198	222	calcium sensing receptor	T116,T192	C0249742
27761213	224	228	CaSR	T116,T192	C0249742
27761213	233	252	calcium homeostasis	T121	C3653518
27761213	265	277	investigated	T169	C1292732
27761213	286	295	CaSR gene	T028	C1413136
27761213	296	305	rs1801725	T028	C0678941
27761213	309	322	A986S variant	T028	C0678941
27761213	327	342	associated with	T080	C0332281
27761213	343	357	susceptibility	T169	C1264642
27761213	361	364	CRC	T191	C1527249
27761213	365	369	risk	T078	C0035647
27761213	401	419	case-control study	T062	C0007328
27761213	428	433	cases	T169	C0868928
27761213	439	442	CRC	T191	C1527249
27761213	451	459	controls	T096	C0009932
27761213	483	491	subjects	T096	C0681850
27761213	497	506	genotyped	T032	C0017431
27761213	511	520	CaSR gene	T028	C1413136
27761213	521	534	A986S variant	T028	C0678941
27761213	541	544	PCR	T063	C0032520
27761213	547	558	RFLP method	T059	C3714764
27761213	560	574	No significant	T033	C1273937
27761213	575	585	difference	T080	C1705242
27761213	590	598	observed	T169	C1441672
27761213	607	620	A986S variant	T028	C0678941
27761213	624	633	CaSR gene	T028	C1413136
27761213	644	652	genotype	T032	C0017431
27761213	656	674	allele frequencies	T081	C0017270
27761213	687	692	cases	T169	C0868928
27761213	701	709	controls	T096	C0009932
27761213	719	723	lack	T080	C0332268
27761213	727	737	difference	T080	C1705242
27761213	774	784	adjustment	T169	C0456081
27761213	789	792	age	T032	C0001779
27761213	794	797	BMI	T201	C1305855
27761213	799	802	sex	T032	C1522384
27761213	804	818	smoking status	T201	C1519386
27761213	824	838	family history	T033	C0241889
27761213	842	845	CRC	T191	C1527249
27761213	847	858	No evidence	T080	C0332125
27761213	867	873	effect	T080	C1280500
27761213	874	886	modification	T033	C3840684
27761213	894	905	association	T080	C0439849
27761213	906	919	A986S variant	T028	C0678941
27761213	924	927	CRC	T191	C1527249
27761213	931	934	BMI	T201	C1305855
27761213	936	939	sex	T032	C1522384
27761213	944	954	tumor site	T082	C0475445
27761213	964	972	observed	T169	C1441672
27761213	991	995	risk	T078	C0035647
27761213	999	1006	obesity	T047	C0028754
27761213	1010	1018	relation	T080	C0439849
27761213	1026	1039	A986S variant	T028	C0678941
27761213	1047	1055	controls	T096	C0009932
27761213	1064	1069	cases	T169	C0868928
27761213	1085	1093	analyzed	T062	C0936012
27761213	1110	1135	no significant difference	T033	C3842396
27761213	1144	1157	normal weight	T033	C2712185
27761213	1159	1162	BMI	T201	C1305855
27761213	1180	1190	overweight	T184	C0497406
27761213	1193	1198	obese	T047	C0028754
27761213	1200	1203	BMI	T201	C1305855
27761213	1217	1225	subjects	T096	C0681850
27761213	1231	1239	findings	T033	C0243095
27761213	1266	1272	effect	T080	C1280500
27761213	1280	1289	CaSR gene	T028	C1413136
27761213	1290	1303	A986S variant	T028	C0678941
27761213	1307	1310	CRC	T191	C1527249
27761213	1311	1315	risk	T078	C0035647
27761213	1336	1343	finding	T033	C0243095
27761213	1353	1365	confirmation	T033	C0750484
27761213	1374	1378	role	T077	C1705810
27761213	1386	1398	gene variant	T028	C0678941
27761213	1402	1416	carcinogenesis	T191	C0596263
27761213	1437	1449	investigated	T169	C1292732